Il Sole 24 Ore S.p.A.
Il Sole 24 Ore S.p.A.
05/14/2024 | Press release | Distributed by Public on 05/14/2024 09:27
Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
Results from a Phase 1 First in human Study of Pemivibart: an[...]
Il Sole 24 Ore S.p.A.
05/14/2024 | Press release | Distributed by Public on 05/14/2024 09:27
Please select the service you want to use:
Smartlinks | Il Sole 24 Ore S.p.A. | Company News | Shareholders | Financial Services | Investment Services | Arts and Culture | Book and Literature | Book Publishing | Entertainment | Media | Media and Publishing | Newspaper and Magazines | News Media | Radio and Television | Securities Issuers | Newspapers and Magazines Publishers | Borsa Italiana | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Berlin Stock Exchange | Stuttgart Stock Exchange | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Euronext Block MTF | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact